Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Plans Additional Clinical Trials Following Successful Tests
Company recently announced significant findings of cardiovascular performance improvements with TurboCBD Lexaria plans additional human clinical trials of CBD Company…